MR. BRIAN KELLY

Lobbying for TAKEDA PHARMACEUTICAL COMPANY · Pharmaceuticals

Filing 1st Quarter - Amendment

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 16, 2025

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Pharmacy

Trade and tariffs

Tariff (miscellaneous tariff bills)

Government tariffs on drug imporatation.

Trade (domestic/foreign)

Trade/Tariffs on drug pricing and importation

Taxation/Internal Revenue Code

tax issues related to drugs and pricing

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.